Home › Neuroendocrine Tumors › Nebraska › Omaha
Neuroendocrine Tumors clinical trials in Omaha, NE
6 studies for Neuroendocrine Tumors are looking for participants at sites in and around Omaha (within about 30 miles). Open a study to see who can join and how to contact the study team.
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
RecruitingPhase 2/3
- University of Nebraska Medical Center, Omaha
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- Children's Hospital and Medical Center of Omaha, Omaha
- University of Nebraska Medical Center, Omaha
Integrated Cancer Repository for Cancer Research
RecruitingObservational studyHealthy volunteers welcome
- Methodist Estabrook Cancer Center, Omaha
- Nebraska Methodist Health System, Omaha
- University of Nebraska Medical Center, Omaha
- and 1 more
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
RecruitingPhase 1/2
- Nebraska Cancer Specialists, Omaha
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
RecruitingPhase 3
- Research Facility, Omaha
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Omaha
Neuroendocrine Tumors trials in other cities
- Philadelphia, PA11 studies
- Washington, DC11 studies
- Rochester, MN9 studies
- Houston, TX8 studies
- St. Louis, MO8 studies
- Columbus, OH8 studies
- Salt Lake City, UT8 studies
- Cleveland, OH7 studies
- Miami, FL7 studies
- Chicago, IL7 studies
- New York City, NY7 studies
- Detroit, MI7 studies
Other studies in Omaha
- Prostate Cancer28 studies
- Non-Small Cell Lung Cancer25 studies
- Breast Cancer23 studies
- Cancer (all types)19 studies
- Colorectal Cancer19 studies
- Multiple Myeloma16 studies
- Ovarian Cancer15 studies
- Non-Hodgkin Lymphoma14 studies
- Metastatic Cancer14 studies
- Pancreatic Cancer14 studies
- Heart Failure13 studies
- Lung Cancer13 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.